Treace Medical Concepts share price logo

Treace Medical Concepts

NASDAQ: TMCI

Small Cap

$4.49

-0.04

(-0.88%)

as on

Treace Medical Concepts Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.46
    $4.68
    downward going graph

    0.67%

    Downside

    4.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.17
    $7.61
    downward going graph

    73.94%

    Downside

    69.45%

    Upside

    downward going graph

Treace Medical Concepts share price movements today

Previous Close
$4.53
Open
$4.57
Volume
245.0K
Market Cap
$296.6M
Day's Low - High
$4.46 - $4.68
52 Week Low - High
$1.17 - $7.61

Treace Medical Concepts Historical Returns

1 Month Return
-0.66 %
3 Month Return
+ 8.11 %
1 Year Return
-34.25 %
3 Year Return
-68.59 %
5 Year Return
-84.37 %

Treace Medical Concepts Stock Fundamentals & Key Indicators

Check Treace Medical Concepts market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$296.6M

EPS (TTM)

-0.93

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.87

Industry PE ratio

-6.75

PEG Ratio

0.27224037229699255

EBITDA

-45.2M

Revenue (TTM)

205.3M

Profit Margin

79.45%

Return On Equity TTM

-74.06%

Treace Medical Concepts Stock Valuation

Track how Treace Medical Concepts P/E has moved over time to understand its valuation trends.

Treace Medical Concepts in the last 5 years

  • Overview

  • Trends

Lowest (-49.14x)

December 31, 2021

Industry (-6.75x)

December 31, 2025

Today (-2.63x)

December 31, 2025

Highest (-2.63x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -2.63x

Treace Medical Concepts vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Treace Medical Concepts with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$296.6M-84.37%-4.8779.45%0.00%
BUY$50.9B-26.1%50.7277.98%0.00%
BUY$119.9B-28.47%22.6866.69%3.08%
BUY$176.6B-19.37%32.8156.80%2.42%
BUY$108.0B2.6%28.7965.17%1.22%

Stock Returns calculator for Treace Medical Concepts Stock including INR - Dollar returns

The Treace Medical Concepts stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Treace Medical Concepts investment value today

Current value as on today

₹70,922

Returns

-₹29,078

(-29.08%)

Returns from Treace Medical Concepts Stock

-₹34,833 (-34.83%)

Dollar Impact

₹5,755 (+5.75%)

Analyst Recommendation on Treace Medical Concepts Stock

Based on 3 analysts

BUY

33.33%

Buy

66.67%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Treace Medical Concepts. Average target price of $5.5

Treace Medical Concepts Share Price Target

Get share price movements and forecasts by analysts on Treace Medical Concepts.

What analysts predicted

18.36%UPSIDE

Target Price

$5.5

Current Price

$4.49

Analyzed by

3 Analysts

Target

$5.50

Treace Medical Concepts target price $5.5, a slight upside of 18.36% compared to current price of $4.49. According to 3 analysts rating.

Indian Investors' Interest in Treace Medical Concepts Stock

Search interest for Treace Medical Concepts Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Treace Medical Concepts Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
51
44
45
68
52
47
50
62
47
45
Gross Profit
40
35
36
55
41
37
39
50
37
35
Operating Income
-18
-21
-15
0
-15
-16
-15
-5
-17
-14
EBITDA
-15
-17
-11
3
-12
-13
-12
-5
-15
-12
Interest Expense
1
1
1
1
1
1
1
1
1
1
Depreciation
1
2
2
2
2
2
2
2
0
1
Income Before Tax
-18
-21
-15
0
-15
-17
-16
-9
-17
-15
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-18
-21
-15
0
-15
-17
-16
-9
-17
-15
Net Profit Margin
80.19%
80.25%
80.14%
80.74%
79.69%
79.67%
79.07%
80.62%
79.26%
78.47%

Treace Medical Concepts Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
39
57
94
141
187
209
212
Gross Profit
31
44
77
114
151
168
169
Operating Income
-3
0
-16
-34
-51
-55
-54
EBITDA
-2
2
-15
-36
-39
-42
-43
Interest Expense
0
4
4
4
5
5
5
Depreciation
0
1
0
2
5
8
10
Income Before Tax
-4
-3
-20
-42
-49
-55
-59
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-4
-3
-20
-42
-49
-55
-59
Net Profit Margin
80.64%
78.26%
82.11%
80.60%
81.20%
80.37%
79.81%

Treace Medical Concepts Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-21
-15
0
-15
-17
-16
-9
-17
-15
Operating Cash Flow
-7
-13
-11
-4
4
-3
-9
-8
7
-4
Investing Cash Flow
3
22
5
3
-1
-3
8
9
-7
7
Financing Cash Flow
0
0
0
0
0
0
0
1
0
0
Change in Cash
-3
8
-6
0
2
-5
0
3
-1
3

Treace Medical Concepts Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-3
-20
-42
-49
-55
-59
Operating Cash Flow
-7
-4
-17
-30
-34
-37
-15
Investing Cash Flow
-1
-1
-2
-76
-81
35
13
Financing Cash Flow
19
11
107
20
109
0
2
Change in Cash
10
5
87
-86
-6
-1
0

Mutual Funds that own Treace Medical Concepts Stock

Check out the Mutual Funds with significant holdings in Treace Medical Concepts.

Funds
Holdings
Shares Held
DFA INVESTMENT DIMENSIONS GROUP INC
0.03964%
25780
John Hancock Variable Insurance Trust
0.025554%
16619
STATE STREET INSTITUTIONAL INVESTMENT TRUST
0.023833%
15500
Victory Portfolios III
0.014838%
9650
Bridge Builder Trust
0.014604%
9498

Global Institutional Holdings in Treace Medical Concepts

Funds
Holdings
Avantis
0.03%
Kenneth Tropin
0.02%
Vanguard
3.35%
Jean Marie Eveillard
2.25%
Xtrackers
0.64%

Insights on Treace Medical Concepts

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -17.96M → -15.87M (in $), with an average increase of 13.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TMCI stock has moved up by 262.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 18.6% return, outperforming this stock by 53.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 22.7% return, outperforming this stock by 90.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 62.51M → 45.37M (in $), with an average decrease of 14.2% per quarter

About Treace Medical Concepts

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
OrganisationTreace Medical Concepts
Headquarters100 Palmetto Park Place, Ponte Vedra, FL, 32081, US
IndustryMedical - Devices
CEOJohn T. Treace
E-voting on sharesClick here to vote

Key Management of Treace Medical Concepts

Name

Title

Dr. Sean F. Scanlan Ph.D.

Chief Innovation & Marketing Officer

Mr. Terry W. Lubben

Chief Operations & Supply Chain Officer

Mr. Brad Barr

Senior Vice President of Sales

Mr. Daniel E. Owens

Chief Human Resources Officer

Ms. Shana Zink

Senior Vice President of Clinical Affairs & Reimbursement

Mr. John T. Treace

Founder, Chairman & CEO

Mr. Mark L. Hair CPA

Chief Financial Officer

Mr. Scot M. Elder J.D.

Chief Legal & Compliance Officer and Corporate Secretary

Mr. Zac Potter

Senior VP & Chief Accounting Officer

Mr. Taylor Erickson

Chief Information & Cybersecurity Officer

FAQs

What is Treace Medical Concepts share price today?

Treace Medical Concepts share price today is $4.49 as on at the close of the market. Treace Medical Concepts share today touched a day high of $4.68 and a low of $4.46.

What is the 52 week high and 52 week low for Treace Medical Concepts share?

Treace Medical Concepts share touched a 52 week high of $7.61 on and a 52 week low of $1.17 on . Treace Medical Concepts stock price today i.e. is closed at $4.49,which is 40.99% down from its 52 week high and 283.76% up from its 52 week low.

What is Treace Medical Concepts's market capitalisation today?

Treace Medical Concepts market capitalisation is $0.00T as on .

How to invest in Treace Medical Concepts Stock (TMCI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Treace Medical Concepts on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Treace Medical Concepts Shares that will get you 0.3341 shares as per Treace Medical Concepts share price of $4.49 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Treace Medical Concepts Stock (TMCI) from India?

Indian investors can start investing in Treace Medical Concepts (TMCI) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Treace Medical Concepts stock (as per the Rupee-Dollar exchange rate as on ). Based on Treace Medical Concepts share’s latest price of $4.49 as on September 19, 2026 at 8:46 am IST, you will get 2.2272 shares of Treace Medical Concepts. Learn more about fractional shares .

What are the returns that Treace Medical Concepts has given to Indian investors in the last 5 years?

Treace Medical Concepts stock has given -84.37% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?